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Thrombin injection for failed stent graft repair of
perforated atherosclerotic aortic ulcer
Robert S. Feld, MD,a Eugene Sullivan, MD,b and Peter Morrison, MD,a Hartford, Conn
We used direct thrombin injection to occlude a pseudoaneurysm that formed from a contained rupture of a penetrating
atherosclerotic ulcer at the junction of the thoracic and abdominal aorta after we failed to seal the perforation with an
endovascular stent graft. The principles of thrombin injection and the technical modifications specific for use in a false
aneurysm of aortic origin are described. An evolving role for thrombin in endovascular therapy is suggested. (J Vasc Surg
2003;37:194-7.)
Percutaneous, image-guided, thrombin injection has
been shown to be effective in treating pseudoaneurysms of
various sites and etiologies. Multiple reports have substan-
tiated direct ultrasound-guided thrombin injection as the
primary therapy for iatrogenic femoral pseudoaneu-
rysms.1,2 False aneurysms of the subclavian, brachial, and
tibial arteries have been occluded with this method.3 Also,
pseudoaneurysms of the splanchic and renal circulation
have been treated with thrombin injected directly with
sonographic or computed tomographic (CT) control.4,5 As
a further extension of this technique, we present a case of
thrombin injection successfully applied to a pseudoaneu-
rysm that persisted after attempted stent graft repair of a
perforated atherosclerotic aortic ulcer.
CASE REPORT
A 68-year-old man on chronic hemodialysis was seen in the
emergency room with upper abdominal and back pain. A spiral CT
scan showed perforation of a calcified aorta, just above the celiac
axis, a 4-cm diameter false aneurysm with a 7-mm diameter neck,
and surrounding, retrocrural hematoma (Fig 1, A). The patient’s
condition was hemodynamically stable. In view of multiple comor-
bidities, including coronary artery and obstructive lung disease, the
patient was considered to be at unacceptable risk for open surgical
repair. Instead, an endovascular approach was undertaken. The
native aorta at the perforation site measured 24 mm on CT scan. In
the operating room, a 26 mm–diameter, 3.75-cm Aneurx aortic
cuff stent graft (Medtronic AVE, Santa Rosa, Calif) was deployed
through a right femoral arteriotomy to cover the site of aortic
perforation while preserving the orifice of the celiac axis (Fig 1, B).
Completion angiography in the operating room showed persistent
leakage despite multiple balloon inflations of the stent graft to
achieve a hemostatic seal. The patient was returned to the intensive
care unit and monitored for 24 hours without change in condition.
A CT scan done 32 hours after the endovascular procedure showed
persistent filling of the false aneurysm and no change in the
retrocrural hematoma (Fig 2, A).
The following day, the patient was returned to CT scan where
direct thrombin injection with CT guidance was performed. The
patient was placed in the gantry in the prone position. A prelimi-
nary CT scan was done with 50 mL of intravenous contrast to
localize the site of leakage. With conscious sedation and local
anesthesia, a 20-guage needle was introduced from a right lateral
intercostal approach and advanced into the pseudoaneurysm, with
care taken to avoid the false aneurysm neck and native aorta (Fig 2,
B). Spontaneous blood return was encountered on entering the
pseudoaneurysm, and a total of 2 mL of sterile saline solution,
containing 2000 units of thrombin (1000 U/mL; Gentrac,
Middleton, Wis), was injected. After the injection, the syringe was
disconnected from the needle, blood flow from the needle was
observed to stop, and the needle was withdrawn. A CT scan was
repeated with 50 mL of contrast, and multiple axial scans were
obtained through the injection site. CT scan attenuation numbers
were recorded in the hematoma over time to assess for filling of the
pseudoaneuysm. No filling was seen (Fig 3, A). A CT scan done 48
hours later showed thrombosis of the false aneurysm, no change in
the retrocrural hematoma, and no new areas of contrast extravasa-
tion.
The patient’s condition stabilized, and he was discharged 2
days after the thrombin injection. Follow-up CT scan done 1
month after discharge showed no leak and shrinkage of the retro-
crural hematoma (Fig 3, B). CT scan done 7 months after the
procedure showed no recurrence of the pseudoaneurysm. A final
follow-up CT scan, 1 year after the procedure, is planned.
DISCUSSION
Recently recognized as a distinct clinical entity, athero-
sclerotic ulcers can penetrate the aortic wall and lead to
dissection, embolization, or, as in this case, rupture and
pseudoaneurysm formation. Several reports of successful
endovascular stent graft repair of perforated aortic ulcers
have appeared.6,7 Our patient was considered a logical
candidate for such an approach because of multiple medical
problems and because of the relatively narrow caliber of the
aorta, 24 mm, above and below the point of hemorrhage, a
feature which, we believed, would produce a seal with the
26 mm–diameter AneuRx aortic cuff available in our inven-
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tory. When this technique failed, we decided to occlude the
pseudoaneurysm directly with thrombin.
Thrombin is a hemostatic agent approved for topical
use on the surface of bleeding tissue. It is supplied as a
freeze-dried sterile powder that is reconstituted for use with
sterile isotonic saline solution. Thrombin requires no im-
mediate physiologic agent for its action but rather clots the
fibrinogen in blood directly.
Success with direct ultrasound-guided thrombin injec-
tion in occluding catheterization-induced femoral
pseudoaneurysms has encouraged workers to apply this
technique to false aneurysms originating in other vascular
beds and from other causes. Kang used sonographically
guided thrombin injection to treat a postinfectious brachial
artery pseudoaneurysm, traumatic superficial femoral and
posterior tibial pseudoaneurysms, and a central venous
catheter-related subclavian artery false aneurysm.3 The
same paper suggested the potential of direct thrombin
injection for side branch endoleaks after endovascular ab-
dominal aortic aneurysm repair, and Van der Berg et al8
reported on just such an application several months later.
Recently, Lin et al9 used a Fogarty catheter to deliver
thrombin into an aortic arch pseudoaneurysm with a wide
neck. Although the false aneurysm neck was occluded with
the Fogerty balloon during the injection, the patient devel-
oped a transient ischemic attack from intracerebral clot
propagation and needed intravenous abciximab for symp-
tom resolution.
In these articles, several principles and caveats for safe
and effective intracavitary instillation of thrombin emerge.
First, direct thrombin injection into a pseudoaneurysm is
feasible because the swirling flow in the pseudoaneurysm
sac permits rapid thrombosis of the sac before any appre-
ciable thrombin can enter the bloodstream. Second, the
neck of the pseudoaneurysm must be narrow compared
with the diameter of the false aneurysm sac itself to mini-
mize escape of thrombin or newly generated thrombus into
the general circulation. Third, the needle or catheter tip
should be directly visualized during the injection to avoid
the parent artery and to recognize the moment of throm-
bosis so that overdosing and overdistension are avoided.
Fourth, multilobed pseudoaneurysms can be treated but
may require separate injections into each lobe. Fifth,
thrombin doses of 1000 to 2000 units usually suffice for
lesions of less than 5 cm. More recent work suggests that
smaller doses, a few hundred units, are adequate for most
iatrogenic false aneurysms in the groin.10 Sixth, although
some authors have recommended the use of balloon cath-
eters or manual neck compression to slow or block flow
within the pseudoaneurysm during injection, such protec-
tive maneuvers are not essential, particularly when the neck
is narrow, and probably are insufficient when the neck is
Fig 1. A, Initial CT scan showing leak from posterior aorta (arrowhead) and pseudoaneurysm (arrow). B, Intraop-
erative aortogram before stent deployment showing leak (long white arrow). Celiac axis is shown with the short white
arrow.
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Fig 3. A, CT scan immediately after thrombin injection showing no filling of pseudoaneurysm in retrocrural
hematoma (arrow). B, CT scan 1 month later with shrinkage of retrocrural hematoma (arrow).
Fig 2. A, CT scan after stent graft placement shows persistent leak (large arrow) and stent in aorta (small arrow). B,
Needle in position of pseudoaneurysm just before thrombin injection. Needle has been placed with patient prone in
gantry, but CT scan image has been inverted to facilitate viewing.
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wide. Seventh, human thrombin is preferred in place of the
bovine preparation in patients with known multiple prior
bovine thrombin exposures to avoid the development of
antibodies to thrombin or factor V and possible allergic or
bleeding complications.
These principles were considered when making our
decision to use thrombin for our patient. The neck or
leakage channel of the aortic perforation measured only 7
mm in diameter compared with 4 cm for the diameter of
the false aneurysm sac, so we believed that thrombin escape
was unlikely and neck occlusion unnecessary. The false
aneurysm sac was unilocular so that multiple injections with
attendant adjustments in needle position would not be
needed. The deep paravertebral location of our patient’s
pseudoaneurysm required us to modify the technique of
ultrasound-directed thrombin injection used for more su-
perficial lesions.
We used CT in place of ultrasound. Although we could
not directly visualize the injection in real time with CT, we
used sequential static CT scan images to monitor the
progression of our needle tip into the sac and to steer the
needle safely away from the aorta. The paravertebral hema-
toma provided a safe extrapulmonary window to the false
aneurysm.
The dose of 2000 units was based on our experience
with femoral pseudoaneurysms. The bovine formulation
was used because the patient had no prior thrombin expo-
sure and hypersensitivity was not a concern. We were
careful to inject slowly, and we were prepared to rescan and
inject more thrombin if leakage persisted on the immediate
postinjection CT scan. After injection, we withdrew the
needle before rescanning to avoid any streak artifact, which
might obscure filling of the false aneurysm sac.
It is unclear why the stent graft did not produce a seal
and what role, if any, it played in the thrombin success. We
thought that the 2-mm oversizing provided by the 26
mm–diameter stent graft was reasonable and that comple-
tion images did show symmetric apposition of the graft to
the aortic wall. Possibly, dense mural calcification pre-
vented a hemostatic closure. More important may have
been the proximity of the leak site to the celiac axis ostium,
which may have precluded adequate coverage of the infe-
rior extent of the perforation in the effort to spare the celiac
origin. Given these obstacles, it may have been preferable,
particularly in retrospect, to have treated with thrombin
injection first and to have reserved endografting as a second
line approach.
With a normal 7-month follow-up CT scan, recurrence
at the prior leak site is unlikely. Should the pseudoaneurysm
return, direct CT scan and fluoroscoically guided injection
of coils and thrombin might be considered.
In summary, our application exemplifies the utility of
thrombin injection in the treatment of a false aneurysm of
aortic origin and the value of thrombin injection as an
adjunctive or alternative technique in the setting of subop-
timal or failed endovascular repair of such lesions.
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